8-11808709-G-GTCCCACTCCCACTCCCAC
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The ENST00000220584.9(FDFT1):c.100-63_100-46dup variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.011 ( 21 hom., cov: 0)
Exomes 𝑓: 0.014 ( 189 hom. )
Consequence
FDFT1
ENST00000220584.9 intron
ENST00000220584.9 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.258
Genes affected
FDFT1 (HGNC:3629): (farnesyl-diphosphate farnesyltransferase 1) This gene encodes a membrane-associated enzyme located at a branch point in the mevalonate pathway. The encoded protein is the first specific enzyme in cholesterol biosynthesis, catalyzing the dimerization of two molecules of farnesyl diphosphate in a two-step reaction to form squalene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 8-11808709-G-GTCCCACTCCCACTCCCAC is Benign according to our data. Variant chr8-11808709-G-GTCCCACTCCCACTCCCAC is described in ClinVar as [Benign]. Clinvar id is 3043487.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDFT1 | NM_004462.5 | c.100-63_100-46dup | intron_variant | ENST00000220584.9 | NP_004453.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDFT1 | ENST00000220584.9 | c.100-63_100-46dup | intron_variant | 1 | NM_004462.5 | ENSP00000220584 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0112 AC: 1662AN: 148918Hom.: 21 Cov.: 0
GnomAD3 genomes
AF:
AC:
1662
AN:
148918
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0136 AC: 18632AN: 1366000Hom.: 189 Cov.: 0 AF XY: 0.0137 AC XY: 9200AN XY: 672602
GnomAD4 exome
AF:
AC:
18632
AN:
1366000
Hom.:
Cov.:
0
AF XY:
AC XY:
9200
AN XY:
672602
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0112 AC: 1662AN: 149030Hom.: 21 Cov.: 0 AF XY: 0.0104 AC XY: 759AN XY: 72632
GnomAD4 genome
AF:
AC:
1662
AN:
149030
Hom.:
Cov.:
0
AF XY:
AC XY:
759
AN XY:
72632
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FDFT1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at